We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
INTEGRA BIOSCIENCES AG

Download Mobile App




In Other News

Image: Many patients with atopic dermatitis modify systemic therapy because of inadequate efficacy, highlighting the need for molecular tools and biomarkers to guide treatment selection. (Image Credit: iStock)

Molecular Skin Test May Help Guide Treatment Selection in Atopic Dermatitis

A new noninvasive gene expression test helps guide systemic treatment in moderate-to-severe atopic dermatitis. Read more
28 Sep 2026 | Molecular Diagnostics
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

A genetic testing program detects inherited cancer risk in young patients and enables family screening to personalize care. Read more
26 Sep 2026 | Molecular Diagnostics
Image: The FLEX study incorporates MammaPrint and BluePrint testing into its data platform to connect genomic tumor characteristics with treatment patterns and long-term outcomes (Photo courtesy of Agendia)

Genomic Breast Cancer Study Adds Real-World Evidence Across Diverse Patient Populations

A large real-world evidence study now links whole-transcriptome profiling with clinical data from more than 25,000 patients. Read more
26 Sep 2026 | Molecular Diagnostics
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

PhAST received U.S. FDA 510(k) clearance for the PhAST instrument and PhAST Blood Culture Gram-negative Panel. Read more
26 Sep 2026 | Microbiology
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

A new collaboration will combine Circular Genomics’ circRNA biomarker platform with Altoida’s AI-powered Digital NeuroMarker platform. Read more
25 Sep 2026 | Industry
Image Credit: 123RF

Mayo Clinic Laboratories and Pathology Asia Expand Genomic Testing Across Asia-Pacific

The collaboration aims to expand access to advanced diagnostics and precision medicine across Southeast Asia, Australia, and New Zealand. Read more
25 Sep 2026 | Industry
Image: The method combines metagenomic sequencing with computational filtering to identify likely disease-causing bacteria and viruses (Image Credit: iStock)

Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

A new computational filter for metagenomic sequencing improves CSF pathogen detection and interpretation in CNS infections. Read more
25 Sep 2026 | Molecular Diagnostics
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

A point-of-care blood test plus a clinical risk score could reduce chest pain emergency visits by about 30%. Read more
25 Sep 2026 | Clinical Chem.
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

A blood-based DNA methylation approach flags prostate cancer risk 5–8 years early and stratifies breast cancer risk. Read more
24 Sep 2026 | Molecular Diagnostics
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

A new urine test measures 31 mycotoxin markers using LC-MS/MS and hydrolysis to reveal masked metabolites, aiding diagnosis. Read more
24 Sep 2026 | Microbiology
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to support earlier Alzheimer’s and dementia diagnosis in the UK. Read more
24 Sep 2026 | Industry
Image: The proposed workflow adds liquid biopsy to detect genetic and molecular signs of cancer in CSF samples already collected during autoimmune encephalitis evaluation. (Image Credit: Shutterstock)

CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

Adding a cerebrospinal fluid liquid biopsy to autoimmune encephalitis evaluations could help detect hidden brain cancers. Read more
24 Sep 2026 | Molecular Diagnostics
Image: Vaginal and urine samples showing endometrial cancer (true positive case; upper row) and no malignant cells (true negative case; lower row). (Jones ER, Narine N, O\'Flynn H, et al. The Lancet Obstetrics, Gynaecology, & Women\'s Health (2026). DOI:10.1016/S3050-5038(26)00222-0.)

Simple Test Could Reduce the Need for Invasive Uterine Cancer Checks

Combined urine and vaginal cytology helps triage postmenopausal bleeding, detecting over 80% of cancers with 98.8% NPV. Read more
24 Sep 2026 | Pathology

Channels

Clinical Chemistry

view channel
Multi-Cancer Blood Test Expands Detection to Cancers Lacking Routine Screening O...
Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Stroke...
Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath ...
Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery
Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic...
Image Credit: iStock

Mpox Analysis Reveals Substantial Suspected False Positives Associated with Contamination

Reliable confirmation of mpox can be difficult where multiple rash-causing illnesses co-circulate and laboratory capacity is limited. Although PCR is central to case detection, contamination during specimen... Read more

Hematology

view channel
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
New Automated Hemostasis Systems Become Available Across US Laboratories
Variation in AML Residual Disease Testing Prompts Push for Standardization
Image Credit: Adobe Stock

New Donor Genetic Marker May Help Predict Stem Cell Transplant Success

Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more

Immunology

view channel
Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy
Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahea...
New Cellular Map May Help Predict Crohn’s Disease Course in Children
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Study Finds Frequent Overlap in Antibodies to Lyme and Other Tick-Borne Pathogen...
Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk
Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalov...
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard ...
Machine Learning Cytology Tool Improves Cancer Cell Identification
Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous...
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic ...
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver ...
Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease...
Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent
Image: Galleri is designed to detect cancer-specific methylation patterns across multiple cancer types before symptoms appear, including cancers without recommended screening (Photo courtesy of GRAIL)

Multi-Cancer Early Detection Test Wins FDA Panel Backing for Approval

GRAIL’s Galleri multi-cancer early detection (MCED) test was reviewed by the Molecular and Clinical Genetics Devices Panel of the U.S. Food and Drug Administration’s (FDA) Medical Devices Advisory Committee.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE